Table 2

Apolipoprotein E genotype of all normal tension glaucoma (NTG) subjects, NTG subjects with progressive visual field loss, and controls

GenotypeAll NTGProgressive NTGControls
NoFrequencyNoFrequencyNoFrequency
2\210.00600.00030.009
2\3160.10360.113370.106
2\4100.06520.038130.037
3\3910.587320.6042080.596
3\4310.200110.207810.232
4\460.03920.03870.02
Total1551.000531.0003491.000